Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid
- 23 February 1997
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 6 (2) , 151-158
- https://doi.org/10.1517/13543784.6.2.151
Abstract
Antimicrobial resistance is a significant nosocomial problem and is of increasing importance in community-acquired infections. One approach for overcoming resistance is the discovery and development of agents with new mechanisms of action. The oxazolidinones make up a relatively new class of antimicrobial agents which possess a unique mechanism of bacterial protein synthesis inhibition. Eperezolid and linezolid are two novel analogues that have demonstrated a variety of positive attributes. These agents inhibit many clinically-significant bacterial species both in vitro and in animal models of human infection. Furthermore they have oral bioavailability, and are well tolerated in humans at doses which produce plasma concentrations in excess of the levels predicted to be necessary for efficacy. In this review, we discuss the key information from the literature that supports the Phase II development of linezolid.Keywords
This publication has 10 references indexed in Scilit:
- Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsJournal of Medicinal Chemistry, 1996
- Resistance to Antibiotics Mediated by Target AlterationsScience, 1994
- Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active EffluxScience, 1994
- Inactivation of Antibiotics and the Dissemination of Resistance GenesScience, 1994
- Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesisAntimicrobial Agents and Chemotherapy, 1988
- In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinonesJournal of Antimicrobial Chemotherapy, 1988
- In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105Antimicrobial Agents and Chemotherapy, 1988
- The mechanism of action of DuP 721, a new antibacterial agent: Effects on macromolecular synthesisBiochemical and Biophysical Research Communications, 1988
- In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1988
- Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721Antimicrobial Agents and Chemotherapy, 1987